Who we are

Meet the team

Claudia Rinciog, MSc

Associate Director in Health Economics

Claudia is a Health Economics Associate Director. Since joining Symmetron in 2013, she specialises in evidence review and economic modelling in many disease areas including bipolar disease, rheumatoid arthritis, obesity, oncology, Parkinson’s disease, cardiovascular and pulmonary disease. She has supported submissions to reimbursement authorities in Europe and North America, and developed poster presentations for international conferences and manuscripts for peer-reviewed publications.

Claudia graduated summa cum laude from Lafayette College in Easton, Pennsylvania, with a double degree in Biochemistry (BSc) and Economics (BA). As part of her senior year Economics thesis, she performed a regression analysis on the impact of household HIV status on the economic well-being of households in Zambia. After graduation, Claudia pursued an MSc in International Health Policy and Health Economics at London School of Economics and Political Science (LSE).

As part of her LSE dissertation, Claudia interned at Medtronic in Tolochenaz, Switzerland, where she performed an explanatory statistical analysis of aortic valve replacement hospital episodes in the NHS from 2000 to 2010.

Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework
Respiratory
Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework
Alex Diamantopoulos, MSc
Claudia Rinciog, MSc
2021
Cost-effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium
Respiratory
Cost-effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium
Alex Diamantopoulos, MSc
Claudia Rinciog, MSc
2020
Cost effectiveness of an insertable cardiac monitor in a high-risk population in the UK
Cardiometabolic health
Cost effectiveness of an insertable cardiac monitor in a high-risk population in the UK
Alex Diamantopoulos, MSc
Laura Sawyer, MSc
Claudia Rinciog, MSc
2019
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
Respiratory
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
Alex Diamantopoulos, MSc
Claudia Rinciog, MSc
2017
Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes
Rare diseases
Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes
Laura Sawyer, MSc
Claudia Rinciog, MSc
2014
An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Oncology
An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)
Alex Diamantopoulos, MSc
Claudia Rinciog, MSc
2014
Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder I Patients with Mixed Episodes
Neurology & mental health
Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder I Patients with Mixed Episodes
Laura Sawyer, MSc
Claudia Rinciog, MSc
2013
Influence of salts and natural organic matter on the stability of bacteriophage MS2
Arthritis and immunology
Influence of salts and natural organic matter on the stability of bacteriophage MS2
Claudia Rinciog, MSc
2010
Aggregation kinetics of cerium oxide nanoparticles in monovalent and divalent electrolytes. Colloids and Surfaces A: Physicochemical and Engineering Aspects
Aggregation kinetics of cerium oxide nanoparticles in monovalent and divalent electrolytes. Colloids and Surfaces A: Physicochemical and Engineering Aspects
Claudia Rinciog, MSc
2010

Stay in touch

Subscribe to Symmetron and stay up to date with recent news and announcements.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Training and workshops
Statistical analysis
Medical writing
Health technology assessment
Health economic modelling
Evidence development